Hostname: page-component-857557d7f7-zntvd Total loading time: 0 Render date: 2025-12-13T22:05:57.440Z Has data issue: false hasContentIssue false
  • English
  • Français

Equity and Costs

Published online by Cambridge University Press:  28 April 2021

Mark V. Pauly
Get access Rights & Permissions [Opens in a new window]

Extract

The task of determining who should or should not have access to a life-prolonging procedure would not be easy even if cost were no consideration. In an era in which rhe health industry has largely converted to the cost cutting religion, or at least the religion of budget limitation, a conversion for which health economics is partly responsible-the task becomes doubly difficult.

At one level, the Massachusetts Task Force on Organ Transplantation has dealt with this task simply by recommending that the final decision be postponed, and that a limited program of organ transplantation he introduced in an “Initial Social Assessment” phase.

Information

Type
Article
Information
Law, Medicine and Healthcare , Volume 13 , Issue 1 , February 1985 , pp. 28 - 31
Copyright
© 1985 American Society of Law, Medicine & Ethics

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, Securing Access to Health Care (U.S. Gov't Printing Office, Washington, D.C.) (Vol. 1 1983) at 4.Google Scholar
These data are derived from Gibson, R. Waldo, D. Levit, K., National Health Expenditures, 1982, Health Care Financing Review 5(1): 1–31 (Fall 1983).Google ScholarPubMed
Eggers, P., Trends in Medicare Reimbursement for End Stage Renal Disease, 1974–79, Health Care Financing Review 6(1): 31–38 (Fall 1984).Google Scholar